Last reviewed · How we verify
NCT06382779
Proximal Humerus Reconstruction After Resection for Tumors : Comparison Between Allograft Prosthetic Composite and Cement Sleeve Prosthetic Composite
trial testing reverse shoulder arthroplasty in Shoulder Disease in 32 participants. Enrolling by invitation.
1 May 2024
Quick facts
| Lead sponsor | Central Hospital, Nancy, France |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 32 |
| Start date | 15 April 2024 |
| Primary completion | 1 May 2024 |
| Estimated completion | 1 May 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- reverse shoulder arthroplasty
Conditions studied
- Shoulder Disease — all drugs for Shoulder Disease →
Sponsor
Central Hospital, Nancy, France
Who can join
18 and older, any sex, with Shoulder Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Proximal humerus is a common site for primary bone tumors and metastatic disease. Reconstruction with reverse shoulder arthroplasty (RSA) after resection is a surgical challenge and presented high risk of complication. The options for reconstruction after proximal humerus tumor resection are limited, and depend on the soft tissue conditions and bone loss. The most commonly used techniques include long cemented stem alone (in case of limited resection), allograft prosthetic composite (APC), massive prosthesis. In some cases two step procedure are performed : first step is resection and RSA with cement sleeve, and second step is APC or massive prosthesis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06382779
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of reverse shoulder arthroplasty
Trials testing the same drug.
- NCT05847062 — Clinical Trial to Analyze Lateralized Models and Medializations of Inverted Arthroplasty. · NA · unknown
- NCT04762667 — Individual Preoperative Planning for RSA · NA · unknown
- NCT03730597 — Glenosphere Size and Scapular Notch in RSA, Prospective Randomized Study · NA · completed
Other recruiting trials for Shoulder Disease
Currently open trials in the same condition.
- NCT07278050 — Interscalene Block vs Serratus Posterior Superior Intercostal Plane Block · NA · recruiting
- NCT06016257 — Using VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study · NA · recruiting
- NCT05960799 — Catheter Over Needle (CON) vs Catheter Through Needle (CTN). · NA · recruiting
- NCT04209504 — Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block · recruiting
- NCT05780229 — Effectiveness of Treatments for Massive Rotator Cuff Tears: Mixed Methodology. · active not recruiting
Other Central Hospital, Nancy, France trials
Trials by the same sponsor.
- NCT06452290 — PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder · NA · not yet recruiting
- NCT07518498 — Hypnosis During Mechanical Ventilation Weaning · NA · not yet recruiting
- NCT07471334 — Prospective Study of Postictal Psychotic Symptoms Occuring After Video-EEG Monitoring in Focal Epilepsies · NA · not yet recruiting
- NCT07414667 — Primary Sjögren's Syndrome: Impact of Quantitative Anti-Ro52 Antibody Analysis on Patient Prognosis and Stratification ( · not yet recruiting
- NCT07415759 — Imaging of Electrical Properties by MRI: Investigation of Age-Related Changes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06382779 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Central Hospital, Nancy, France
- Last refreshed: 24 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06382779.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing